High intensity focused ultrasound ablation for pain caused by bone metastasesStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Ruxolitinib for treating moderate to severe chronic graft-versus-host disease after an allogeneic stem cell transplant in people 28 days to 17 years TSID 11982Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Subcutaneous isatuximab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma after 1 or more treatments TSID 11969Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC